Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Encinitas, CA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
San Diego, CA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Denver, CO
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
New Haven, CT
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Norwalk, CT
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Norwalk, CT
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Port St. Lucie, FL
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Port St. Lucie, FL
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Honolulu, HI
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Fairway, KA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Fairway, KA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
New Orleans, LA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Rockville, MD
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Boston, MA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Rochester, MN
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Omaha, NE
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Las Vegas, NV
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Lake Success, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
New York, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Rochester, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Stony Brook, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Huntersville, NC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Huntersville, NC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Raleigh, NC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Cleveland, OH
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Providence, RI
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Greenville, SC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Myrtle Beach, SC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Memphis, TN
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Dallas, TX
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Norfolk, VA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Seattle, WA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study
Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study
Status: Enrolling
Updated:  2/12/2014
Stanford University School of Medicine
mi
from
Stanford, CA
Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study
Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective Study
Status: Enrolling
Updated: 2/12/2014
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLOFOX or FOLFIRI
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLOFOX or FOLFIRI in Patients With Newly Diagnosed Ras Mutant Positive Metastatic Colorectal Cancer or Patients With Ras Mutant Positive Colorectal Cancer Who Have Just Completed a First Line Therapy With an Oxaliplatin or Irinotecan Plus Fluoropyrimidine and Bevacizumab Containing Regimen
Status: Enrolling
Updated:  2/12/2014
Georgetown University
mi
from
Washington,
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLOFOX or FOLFIRI
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLOFOX or FOLFIRI in Patients With Newly Diagnosed Ras Mutant Positive Metastatic Colorectal Cancer or Patients With Ras Mutant Positive Colorectal Cancer Who Have Just Completed a First Line Therapy With an Oxaliplatin or Irinotecan Plus Fluoropyrimidine and Bevacizumab Containing Regimen
Status: Enrolling
Updated: 2/12/2014
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
Center for Pain & Supportive Care
mi
from
Scottsdale, AZ
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
Center for Pain & Supportive Care
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
Coastal Pain Research
mi
from
Carlsbad, CA
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
Coastal Pain Research
mi
from
Carlsbad, CA
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
University of California San Deigo
mi
from
La Jolla, CA
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
University of California San Deigo
mi
from
La Jolla, CA
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
Neurovations
mi
from
Napa, CA
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
Neurovations
mi
from
Napa, CA
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
Millenium Pain Center
mi
from
Bloomington, IL
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
Millenium Pain Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
Global Scientific Innovations
mi
from
Evansville, IN
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
Global Scientific Innovations
mi
from
Evansville, IN
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
Center for Pain Management
mi
from
St. Louis, MO
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
Center for Pain Management
mi
from
St. Louis, MO
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
The Center for Clinical Research
mi
from
Winston-Salem, NC
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
The Center for Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated:  2/14/2014
Pain Research of Oregon
mi
from
Eugene, OR
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN
Status: Enrolling
Updated: 2/14/2014
Pain Research of Oregon
mi
from
Eugene, OR
Click here to add this to my saved trials
Radial Reload Laparoscopic Case Series
Evaluating the Radial Reload Stapler With Tri-Staple TM Technology During Laparoscopic Low Anterior Resection for Rectal Cancer: A Prospective Multicenter Case Series
Status: Enrolling
Updated:  2/20/2014
University Hospitals of Cleveland
mi
from
Cleveland, OH
Radial Reload Laparoscopic Case Series
Evaluating the Radial Reload Stapler With Tri-Staple TM Technology During Laparoscopic Low Anterior Resection for Rectal Cancer: A Prospective Multicenter Case Series
Status: Enrolling
Updated: 2/20/2014
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Status: Enrolling
Updated:  2/20/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
Status: Enrolling
Updated: 2/20/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Detection of Sentinel Lymph Nodes in Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging: Comparison of Isosulfan Blue and Indocyanine Green Dyes With Fluorescence Imaging
Status: Enrolling
Updated:  2/20/2014
Florida Hospital Gynecologic Oncology
mi
from
Orlando, FL
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Detection of Sentinel Lymph Nodes in Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging: Comparison of Isosulfan Blue and Indocyanine Green Dyes With Fluorescence Imaging
Status: Enrolling
Updated: 2/20/2014
Florida Hospital Gynecologic Oncology
mi
from
Orlando, FL
Click here to add this to my saved trials
Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers
Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
Status: Enrolling
Updated:  2/21/2014
Stanford University
mi
from
Stanford, CA
Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers
Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
Status: Enrolling
Updated: 2/21/2014
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer
Trans-Arterial Chemo-Embolization (TACE) vs TACE Plus Stereotactic Body Radio Therapy (SBRT) in the Treatment of Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  2/24/2014
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer
Trans-Arterial Chemo-Embolization (TACE) vs TACE Plus Stereotactic Body Radio Therapy (SBRT) in the Treatment of Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 2/24/2014
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Mammaglobin-A DNA Vaccine in Breast Cancer Patients With Metastatic Disease
Status: Enrolling
Updated:  2/27/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Mammaglobin-A DNA Vaccine in Breast Cancer Patients With Metastatic Disease
Status: Enrolling
Updated: 2/27/2014
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials